Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

Slides:

Advertisements

Similar presentations

Volume 59, Issue 2, Pages (February 2001)

Advertisements

Steven Fishbane, Jeffrey S. Berns, M.D. Kidney International

Volume 66, Issue 1, Pages (July 2004)

Associations Between Low Serum Testosterone and All-Cause Mortality and Infection- Related Hospitalization in Male Hemodialysis Patients: A Prospective.

Beta blockers in the management of chronic kidney disease

Volume 69, Issue 11, Pages (June 2006)

Anemia management in chronic kidney disease

Volume 55, Issue 2, Pages (February 1999)

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,

Volume 64, Pages S3-S12 (December 2003)

Type of vascular access and mortality in U.S. hemodialysis patients

Volume 61, Issue 3, Pages (March 2002)

Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease Johannes F.E. Mann, Qi-Long.

Volume 68, Issue 6, Pages (December 2005)

Abnormalities in lipoprotein metabolism in hemodialysis patients

Survival advantage in Asian American end-stage renal disease patients1

Renal risk scores: Progress and prospects

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Volume 65, Issue 2, Pages (February 2004)

Volume 68, Issue 1, Pages (July 2005)

Edmund G. Lowrie Kidney International

Study of Heart and Renal Protection (SHARP)

U-shaped effect of eGFR and mortality

Volume 74, Issue 8, Pages (October 2008)

The analysis of survival data: the Kaplan–Meier method

Acute myocardial infarction in patients with end-stage renal disease

Body size and outcomes on peritoneal dialysis in the United States

Anemia as a risk factor for cardiovascular disease

Blood pressure targets in hemodialysis patients

Locking of tunneled hemodialysis catheters with gentamicin and heparin

Volume 62, Issue 1, Pages (July 2002)

Volume 61, Issue 1, Pages (January 2002)

Volume 89, Issue 5, Pages (May 2016)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 61, Issue 2, Pages (February 2002)

Individuals with severe knee OA are at increased risk of all-cause and cardiovascular disease-specific mortality: The johnston county osteoarthritis project

Alternate-day dialysis may be needed for hemodialysis patients

Non–high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease Yoshiki Nishizawa,

Alfonso M. Cueto-Manzano, Ricardo Correa-Rotter Kidney International

Simvastatin in nephrotic syndrome

Volume 68, Issue 2, Pages (August 2005)

Lynda Anne Szczech, Ira L. Lazar Kidney International

Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival.

Volume 67, Issue 5, Pages (May 2005)

Volume 56, Pages S213-S215 (July 1999)

Volume 67, Pages S55-S62 (January 2005)

Daily nocturnal home hemodialysis

Volume 72, Issue 2, Pages (July 2007)

Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant Chirag R. Parikh, Peter Mcsweeney,

Atherosclerotic nephropathy

Volume 72, Issue 2, Pages (July 2007)

Volume 63, Issue 3, Pages (March 2003)

Volume 80, Issue 10, Pages (November 2011)

Volume 60, Issue 6, Pages (December 2001)

Charles A. Herzog Kidney International

Importance of blood pressure control in hemodialysis patient survival

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1 William M.

Volume 59, Issue 2, Pages (February 2001)

Volume 64, Issue 4, Pages (October 2003)

Volume 64, Issue 3, Pages (September 2003)

Evaluation of the Losartan in Hemodialysis (ELHE) Study

Volume 67, Issue 6, Pages (June 2005)

Graft flow as a predictor of thrombosis in hemodialysis grafts

Lipoprotein abnormalities in diabetic nephropathy

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Volume 57, Pages S44-S48 (April 2000)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Volume 60, Issue 1, Pages (July 2001)

Presentation transcript:

Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa Kidney International Volume 56, Pages S251-S253 (July 1999) DOI: 10.1046/j.1523-1755.1999.07167.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan-Meier statistical analysis. Percent survival over 28 months in 390 patients stratified by Lp(a) ≥ 30 mg/dl (dashed line) vs. < 30 mg/dl (solid line). P < 0.05. Kidney International 1999 56, S251-S253DOI: (10.1046/j.1523-1755.1999.07167.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 Relative risk for death in relation to overall and atherosclerotic causes. Adjustments were made for age, diabetic state, and albumin concentration (N = 390). High Lp(a): ≥ 30 mg/dl; low Lp(a): < 30 mg/dl. Kidney International 1999 56, S251-S253DOI: (10.1046/j.1523-1755.1999.07167.x) Copyright © 1999 International Society of Nephrology Terms and Conditions